PERMANENTLY CHARGED SODIUM AND CALCIUM CHANNEL BLOCKERS AS ANTI-INFLAMMATORY AGENTS
申请人:President and Fellows of Harvard College
公开号:EP3485881A1
公开(公告)日:2019-05-22
The present invention relates to a composition, optionally a pharmaceutical composition, comprising cysteine-derived compounds as defined in Formula (XII). The compound may be used in a method for treating neurogenic inflammation in a human patient.
本发明涉及一种组合物,也可以是一种药物组合物,其中包含如式(XII)所定义的半胱氨酸衍生化合物。该化合物可用于治疗人类患者神经源性炎症的方法中。